Is pelvic lymphadenectomy really necessary in patients with a serum prostate-specific antigen level of <10 ng/ml undergoing radical prostatectomy for prostate cancer?

被引：20
|
作者：
Burkhard, FC [1 ]
Schumacher, M [1 ]
Thalmann, GN [1 ]
Studer, UE [1 ]
机构：
[1] Univ Bern, Dept Urol, Bern, Switzerland
来源：
BJU INTERNATIONAL | 2005年 / 95卷 / 03期
关键词：
D O I：
10.1111/j.1464-410X.2005.05280.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：275 / 278
页数：4
相关论文
共 50 条
  • [41] Probability of prostate cancer as a function of the percentage of free prostate-specific antigen in patients with a non-suspicious rectal examination and total prostate-specific antigen of 4–10 ng/ml
    L. Martínez-Piñeiro
    J. M. García Mediero
    P. González Gancedo
    A. Tabernero
    D. Lozano
    J. J. López-Tello
    J. M. Alonso-Dorrego
    C. Núñez
    M. L. Picazo
    R. Madero
    J. J. De La Peña
    [J]. World Journal of Urology, 2004, 22 : 124 - 131
  • [42] Outcome of prostate cancer patients with initial PSA≥ 20 ng/ml undergoing radical prostatectomy
    Zweryel, Ulrike
    Suttmann, Henrik
    Schroeder, Thomas
    Siemer, Stefan
    Wullich, Bernd
    Kamradt, Joern
    Lehmann, Jan
    Stoeckle, Michael
    [J]. EUROPEAN UROLOGY, 2007, 52 (04) : 1058 - 1066
  • [43] Serum-to-urinary prostate specific antigen ratio: Its impact in distinguishing prostate cancer when serum prostate specific antigen level is 4 to 10 NG/ML.
    Irani, J
    Millet, C
    Levillain, P
    Dore, B
    Begon, F
    Aubert, J
    [J]. JOURNAL OF UROLOGY, 1997, 157 (01): : 185 - 188
  • [44] Salvage radiotherapy in patients with persisting prostate-specific antigen after radical prostatectomy for prostate cancer
    Bottke, D
    Wiegel, T
    Höcht, S
    Müller, M
    Schostak, M
    Hinkelbein, W
    [J]. ONCOLOGY, 2003, 65 : 18 - 23
  • [45] Impact of pathological tumor stage for salvage radiotherapy after radical prostatectomy in patients with prostate-specific antigen < 1.0 ng/ml
    Rei Umezawa
    Hisanori Ariga
    Yoshihiro Ogawa
    Keiichi Jingu
    Haruo Matsushita
    Ken Takeda
    Keisuke Fujimoto
    Toru Sakayauchi
    Toshiyuki Sugawara
    Masaki Kubozono
    Kakutaro Narazaki
    Eiji Shimizu
    Yoshihiro Takai
    Shogo Yamada
    [J]. Radiation Oncology, 6
  • [46] Complexed prostate-specific antigen, and complext prostate-specific antigen indices for early detection of prostate cancer in men with total prostate-specific antigen between 2.0 and 4.0 ng/ml
    Reissigl, A
    Remzi, M
    Wiunig, C
    Zlotta, A
    Ravery, V
    Hammerer, P
    Dobronski, P
    Kaisary, A
    Marberger, M
    Djavan, B
    [J]. JOURNAL OF UROLOGY, 2003, 169 (04): : 426 - 427
  • [47] DISTANT METASTASIS AFTER RADICAL PROSTATECTOMY IN PATIENTS WITHOUT AN ELEVATED SERUM PROSTATE-SPECIFIC ANTIGEN LEVEL
    LEIBMAN, BD
    DILLIOGLUGIL, O
    WHEELER, TM
    SCARDINO, PT
    [J]. CANCER, 1995, 76 (12) : 2530 - 2534
  • [48] Diagnostic efficacy of free prostate-specific antigen/total prostate-specific antigen ratio for the diagnosis of prostate cancer in low concentration (≤4 ng/ml) and intermediate levels of total prostate-specific antigen (4.01-10.0 ng/ml)
    Caliskan, Selahattin
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2017, 13 (02) : 279 - 283
  • [49] Evaluation of the Prostate Imaging Reporting and Data System for Magnetic Resonance Imaging Diagnosis of Prostate Cancer in Patients with Prostate-specific Antigen &lt;20 ng/ml
    Wang, Xuan
    Wang, Jian-Ye
    Li, Chun-Mei
    Zhang, Ya-Qun
    Wang, Jian-Long
    Wan, Ben
    Zhang, Wei
    Chen, Min
    Li, Sa-Ying
    Wan, Gang
    Liu, Ming
    [J]. CHINESE MEDICAL JOURNAL, 2016, 129 (12) : 1432 - 1438
  • [50] Transrectal Saturation Technique May Improve Cancer Detection as an Initial Prostate Biopsy Strategy in Men with Prostate-specific Antigen &lt;10 ng/ml
    Li, Yong-Hong
    Elshafei, Ahmed
    Li, Jianbo
    Gong, Michael
    Susan, Luay
    Fareed, Khaled
    Jones, J. Stephen
    [J]. EUROPEAN UROLOGY, 2014, 65 (06) : 1178 - 1183
12345